EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Is there a place for psychedelics in sports practice?

Marina A M Portes, Isabel Werle, Leandro J Bertoglio iD

Acta Neuropsychiatrica · 2025

DOI: 10.1017/neu.2025.13 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Neuropsychiatrica, 2025. Verfasst von Marina A M Portes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil. Hauptthemen laut MEDLINE: Hallucinogens, Athletes, Sports, Athletic Performance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 261 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing evidence suggests that psychedelic-assisted therapies can alleviate depression, anxiety, posttraumatic stress, and substance use disorder, offering relatively safe profiles, enhanced efficacy, and lasting effects after a few applications. Athletes often experience high levels of stress and pressure, making them susceptible to these psychiatric conditions. However, the effects of psychedelic substances on athletic performance remain largely unknown. Before potential acceptance, evaluating their impact on physical and physiological measures beyond mental health outcomes is crucial. Here, we aim to explore this topic and highlight research directions to advance our understanding. Preclinical studies suggest that psilocybin/psilocin, lysergic acid diethylamide (LSD), N , N -dimethyltryptamine (DMT), and ayahuasca possess anti-inflammatory and anti-nociceptive properties. Studies investigating the effects of classical psychedelics or 3,4-methylenedioxymethamphetamine (MDMA) on factors such as muscle strength, motor coordination, locomotion, endurance, fluid and electrolyte balance, hormonal regulation, and metabolism are still scarce. While adhering to regulatory frameworks, further research in animal models, athletes, and non-athletes is needed to address these gaps, compare psychedelics with commonly used psychoactive drugs, and explore the potential prophylactic and regenerative benefits of specific interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensAthletesSportsAthletic PerformanceHumansAnimalsLysergic Acid DiethylamidePsilocybin

Stichwörter der Autor:innen

CannabisEcstasyInflammationKetamineNeuroplasticityPainResilienceSerotonin

Substanzen

HallucinogensLysergic Acid DiethylamidePsilocybin

Autor:innen und Institutionen

  • Department of Pharmacology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.

ORCID-Profile: Leandro J Bertoglio

Zitieren

APA

Portes, M. A. M., Werle, I., & Bertoglio, L. J. (2025). Is there a place for psychedelics in sports practice?. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2025.13

Vancouver

Portes MAM, Werle I, Bertoglio LJ. Is there a place for psychedelics in sports practice?. Acta Neuropsychiatrica. 2025. doi:10.1017/neu.2025.13

BibTeX
@article{Portes2025,
  author = {Portes, Marina A M and Werle, Isabel and Bertoglio, Leandro J},
  title = {Is there a place for psychedelics in sports practice?},
  journal = {Acta Neuropsychiatrica},
  year = {2025},
  doi = {10.1017/neu.2025.13}
}
Kostenlos starten →